4HF Biotec uses of a wide range of data to reveal vulnerabilities, drug sensitivity and predictive biomarkers for cancers. The data are unified in a platform dedicated to study tumor biology and drug efficacy.

​

Our database contains data of several thousands of patient tumors and established models that have been annotated with millions of data points comprising drug sensitivity profiles (tested in vitro and in vivo) and molecular characteristics (such as exome mutations, chromosomal aberrations/gene copy number variations and expression profiles). It has specific tools, widgets and statistical analyses to connect key metrics.

​

The platform analyzes data from multiple sources in a single view thereby optimizing the process of target evaluation and facilitating R&D efforts in drug discovery.